Total Funding
54
66
Total FundingPost-IPO Equity raised
Growth Score
-2 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
6236
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
- Vivek Ramaswamy: Founder and Executive ChairmanPast Role: Sio Gene Therapies, CEO
- Mayukh Sukhatme: Chief Investment Officer & PresidentPast Role: Apple Tree Partners, Partner
About the Company
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates.
Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and
healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.
